Schmal C

ORCID: 0009-0007-4826-8910 · 1 paper in corpus
2026
JBMR plus ·doi:10.1093/jbmrpl/ziag093

Teriparatide, (recombinant human PTH 1-34) is an Food and Drug Administration (FDA)-approved anabolic therapy for osteoporosis. In patients with severe bone loss, daily teriparatide injections increase osteoblastic activity and bone turnove…